Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Facephi BiometriaXMAD:FACE -0.57%70 Days Sales Outstanding is 154.09 as of Dec. 2025, which is 20% below its 10-year median of 191.90. GuruFocus rates XMAD:FACE with a GF Score™ of 70/100 and a GF Value™ of €3.06 (Possible Value Trap). The stock has 3 warning signs investors should review. Among 2,763 Software companies, Facephi Biometria ranks worse than 90.16% on this metric.
Facephi Biometria (XMAD:FACE) Days Sales Outstanding Explanation
For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.
Facephi Biometria Days Sales Outstanding Related Terms
Facephi Biometria Days Sales Outstanding Historical Data
* Premium members only.
The historical data trend for Facephi Biometria's Days Sales Outstanding can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
XMAD:FACE vs CRM, SHOP, UBER: Days Sales Outstanding Comparison
For the Software - Application subindustry, Facephi Biometria's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Facephi Biometria Days Sales Outstanding vs Software Industry
For the Software industry and Technology sector, Facephi Biometria's Days Sales Outstanding distribution charts can be found below:
* The bar in red indicates where Facephi Biometria's Days Sales Outstanding falls into.
Facephi Biometria Days Sales Outstanding Calculation
Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
What does a Days Sales Outstanding of 154.09 mean?
Facephi Biometria (XMAD:FACE) has a Days Sales Outstanding of 154.09 as of Dec. 2025. Days sales outstanding represents the average amount of days a company takes to collect receivables. View historical data on Facephi Biometria and its competitors. This is 20% below median its historical median of 191.90. Over the past decade, Facephi Biometria's Days Sales Outstanding has ranged from 51.26 to 309.77. According to the industry distribution chart, Facephi Biometria ranks #2491 out of 2763 companies in the Software industry, placing it in the top 90.2%.
Is Facephi Biometria's Days Sales Outstanding too high?
Facephi Biometria's current Days Sales Outstanding of 154.09 is 20% below median its 10-year median of 191.90. Over the past 10 years, this metric has ranged from a low of 51.26 to a high of 309.77. The Software industry median Days Sales Outstanding is 60.64. Facephi Biometria's value of 154.09 is 154.1% above this industry median. Based on the distribution chart, Facephi Biometria ranks #2491 out of 2763 companies in the Software industry, which is in the bottom quartile relative to peers. Overall, Facephi Biometria has a GF Score™ of 70/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Facephi Biometria's Days Sales Outstanding compare to CRM and SHOP?
According to the Software industry distribution chart, Facephi Biometria ranks #2491 out of 2763 companies for Days Sales Outstanding. This places Facephi Biometria in the lower half of its industry. The industry median Days Sales Outstanding is 60.64. Facephi Biometria's value of 154.09 is 154.1% above this benchmark. Historically, Facephi Biometria's own Days Sales Outstanding has ranged from 51.26 to 309.77 over the past decade. While the company's 10-year median is 191.90 vs. the industry median of 60.64, Facephi Biometria has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Sales Outstanding for a Software company?
The median Days Sales Outstanding among Software companies is 60.64, based on 2,763 companies in the industry. Companies in the top quartile (top 25%) have a Days Sales Outstanding significantly above this median, while those in the bottom quartile fall well below. However, Days Sales Outstanding should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Facephi Biometria's current Days Sales Outstanding of 154.09 is 154.1% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Sales Outstanding mean?
A high Days Sales Outstanding can signal that a stock is expensive relative to its fundamentals. Days sales outstanding represents the average amount of days a company takes to collect receivables. View historical data on Facephi Biometria and its competitors. For the Software industry, the median Days Sales Outstanding is 60.64 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Facephi Biometria's current Days Sales Outstanding is 154.09, which is 20% below median its own 10-year median of 191.90. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Facephi Biometria stock overvalued right now?
Based on GuruFocus' analysis, Facephi Biometria (XMAD:FACE) is currently considered Possible Value Trap. The stock's GF Value™ is €3.06, compared to a current price of €1.75 — trading 42.8% below its estimated fair value. The current Days Sales Outstanding is 154.09, which is 20% below median its 10-year median of 191.90 and 154.1% above the Software industry median of 60.64. Facephi Biometria's overall GF Score™ is 70/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Sales Outstanding calculated?
Days Sales Outstanding is calculated from a company's financial statements. For Facephi Biometria (XMAD:FACE), the current Days Sales Outstanding is 154.09 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Facephi Biometria (XMAD:FACE) Overvalued in 2026?
Based on GuruFocus' analysis, Facephi Biometria stock appears to be undervalued.
The current stock price of €1.75 is trading 42.8% below its estimated GF Value™ of €3.06.
GuruFocus considers Facephi Biometria to be Possible Value Trap.
Key valuation signals for XMAD:FACE:
Days Sales Outstanding: 154.09 (20% below median its 10-year median of 191.90)
GF Value™: €3.06 vs. price of €1.75 (42.8% below fair value)
Industry Position: 154.1% above the Software median (#2491 of 2763)
No single metric tells the full story. See the XMAD:FACE stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Facephi Biometria SA is a technology company specializing in digital identity verification, fraud prevention, and regulatory compliance solutions. It delivers an AI/ML-powered Identity & Anti-Fraud platform that provides a comprehensive 360-degree end-to-end approach to digital protection. It develops solutions that make digital processes safer, more accessible, and fraud-free. Its technologies help prevent identity theft while ensuring the ethical management and protection of personal data. Geographically, it operates in Spain and the rest of Countries with the majority of the revenue from the rest of Countries.
70GF Score
Get the complete analysis for XMAD:FACE
Days Sales Outstanding is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
XMAD:FACE has been successfully added to your 
